Cannabis Rescheduling: Balancing Tax Benefits with Rising Compliance Costs
The potential rescheduling of cannabis by the federal government presents an intricate challenge for the industry. While many hoped for a decrease in tax burdens, the anticipated compliance costs appear poised to offset these benefits. As cannabis moves from a Schedule I to a Schedule III substance under the Controlled Substances Act, companies operating in…